Previous studies found that a low circulating IGF-1 level was independently related to insulin resistance and hyperglycaemia (25, 26, 30), while a normal to high circulating IGF-1 level independently led to a reduced prevalence of MetS (31). Here, IGF1 is linked to metabolic syndrome.